A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma

Summary

The purpose of this study is to evaluate the efficacy and safety of TAC-101 after Transcatheter Arterial Chemoembolization (TACE) in patients with advanced, unresectable hepatocellular carcinoma (HCC) who are being scheduled for TACE.

Timeline

Start

2008-10

Primary completion

2008-12

Completion

2008-12

Outcome

Outcome not reported

Stopped: “Terminated due to safety concerns.”

Drugs

Indications